Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 16,959 | 14,607 | 17,971 | 17,054 | 18,003 |
| Gross Profit | 16,959 | 14,607 | 17,971 | 17,054 | 18,003 |
| Operating Expenses | 40,502 | 44,461 | 42,156 | 49,820 | 52,889 |
| Operating Income | -23,543 | -29,854 | -24,185 | -32,766 | -34,886 |
| Interest Expense | 1,962 | 2,581 | 2,355 | 2,563 | 3,441 |
| Other Income | 2,799 | 3,249 | 3,487 | 3,809 | 4,298 |
| Pre-tax Income | -22,706 | -29,186 | -23,053 | -31,520 | -34,029 |
| Income Tax | -416 | -363 | -395 | -363 | -622 |
| Net Income Continuous | -22,290 | -28,823 | -22,658 | -31,157 | -33,407 |
| Net Income | $-22,290 | $-28,823 | $-22,658 | $-31,157 | $-33,407 |
| EPS Basic Total Ops | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 |
| EPS Basic Continuous Ops | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 |
| EPS Diluted Total Ops | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 |
| EPS Diluted Continuous Ops | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 |
| EPS Diluted Before Non-Recurring Items | -1.05 | -1.36 | -1.07 | N/A | N/A |
| EBITDA(a) | $-22,022 | $-30,577 | $-23,826 | $-32,120 | $-33,970 |